Breast Cancer News and Research

Latest Breast Cancer News and Research

FDA panel will help decide fate of drug Evista for preventing breast cancer

Before the osteoporosis drug Evista is approved for breast cancer in the U.S. the Food and Drug Administration (FDA) will take the advice of an advisory panel.

23 Jul 2007

Gold nanorods identify metastatic tumor cells

Using a series of gold nanorods, each with its own characteristic optical signature, researchers at Purdue University have developed a method for rapidly assaying the cellular composition of breast tumors.

23 Jul 2007

Latest drugs improve survival for metastatic breast cancer

Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.

23 Jul 2007

Group therapy does not prolong the lives of women with metastatic breast cancer

Earlier results from the same researcher had suggested a survival benefit of group therapy for women with metastatic breast cancer. However, the new study did find that women with estrogen receptor (ER) negative tumors did show survival benefit, and that group therapy improved quality of life (QOL).

23 Jul 2007

Arius begins toxicology program for lead anti-cancer antibody

ARIUS Research Inc has announced that the Company has initiated the first study in the formal pre-clinical toxicology program for its lead anti-CD44 drug candidate, which is under development for the treatment of breast, prostate and liver cancers.

23 Jul 2007

Implications of a false-positive breast cancer test results

According to a new study in Value in Health, women coping with the strain of being mistakenly diagnosed with breast cancer have not been adequately studied in the past.

20 Jul 2007

Cancer survivors share their advice in new book

Few chemotherapy patients would think to decorate their bald heads with stickers of bowling balls, or of bunny rabbits saying, "Wish you were hare."

18 Jul 2007

Cancer risk from radiation during cardiac CT scans studied

An analysis based on computerized simulation models suggests that the lifetime risk of cancer associated with radiation exposure from a computed tomography (CT scan) coronary angiography varies widely, with the risk greater for women and younger patients, according to a study in the July 18 issue of JAMA .

18 Jul 2007

Vegetable, fruit and fiber rich - low fat diet, does not appear to reduce breast cancer recurrence

Women with early stage breast cancer who adopted a diet very high in vegetables, fruit and fiber and low in fat did not have a lower risk of breast cancer recurrence compared to women who followed a diet of five or more servings a day of fruit and vegetables (the "5-A-Day" diet), according to a study in the July 18 issue of JAMA: The Journal of the American Medical Association.

18 Jul 2007

Impact of food-cancer drug interactions

A commentary in the Journal of Clinical Oncology (JCO) urges researchers to explore an intriguing approach to reduce the dose, and therefore the cost, of oral targeted cancer therapies.

18 Jul 2007

Healthy diet does not prevent recurrence of breast cancer

According to new research following a low-fat diet high in vegetables, fruit and fiber does not prevent breast cancer from returning or prolong the survival of patients.

17 Jul 2007

Breast cancer drug works better on a full stomach

Experts in the United States say that eating the right food with certain medications could improve the effectiveness of drugs and also reduce the cost of treating patients.

17 Jul 2007

Grapefruit linked to increased risk for breast cancer

It seems unlikely but researchers in the United States say they have found that eating too much grapefruit could increase the risk of breast cancer.

17 Jul 2007

Drug-drug or drug-food interactions may offer opportunities to lower costs

Exploiting interactions between food and drugs could dramatically lower the rapidly rising costs of several anticancer drugs, and perhaps many other medications, two cancer-pharmacology specialists suggest in a commentary in the July 16, 2007, issue of the Journal of Clinical Oncology.

17 Jul 2007